Intended for healthcare professionals
Search
Toggle navigation
Current issue
Archive
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
Editorial board
For authors
Advertising
Contact us
News
Web Exclusives
Register
FREE
Sign in
×
Remember me
Not registered?
Forgot your password?
Monk's moments: Too much of a good thing
Barry Monk
As a hospital doctor, I can only imagine what goes on in general practice, particularly when a patient is being referred to a consultant. In Bedford, where I work, we are particularly fortunate in that GPs and hospital specialists tend to know each other, so I fondly imagine that when a GP is faced with a challenging rash, he says something along the lines of, ‘I’ll send you along to see my old friend Barry; he’s a bit of a grumpy old devil, but don’t take any notice because he’ll sort your skin out for you’.
Dermatology in practice
2007;
15
(1): 30–30
To continue reading this article, please
sign in
or
register
.
Follow us on
|
|
Latest News
Dermaliq and DEBRA enter epidermolysis bullosa partnership
FDA grants interchangeable designation to Celltrion’s Yuflyma
GSK’s linerixibat shows promise in PBC-related itch
FDA approves Abeona’s Zevaskyn to treat epidermolysis bullosa
Sanofi/Regeneron announce FDA approval for Dupixent in urticaria
This site uses cookies in order to function properly and to allow us to improve our service. By using this site you consent to the use of cookies as set out in our
privacy policy